Great West Life Assurance CO Arrowhead Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$49.6 Billion
Q1 2024

A detailed history of Great West Life Assurance CO transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 90,571 shares of ARWR stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,571

Previous 82,506 9.78%

Holding current value

$2.27 Million

Previous $2.52 Million 2.78%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.21 - $39.48 $219,448 - $318,406	8,065 Added 9.78%	90,571 $2.59 Million
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $43,396 - $63,518	-2,047 Reduced 2.42%	82,506 $2.52 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $186,963 - $257,466	7,136 Added 9.22%	84,553 $2.27 Million
Q2 2023 Aug 10, 2023	SELL	$25.16 - $41.38 $151,060 - $248,445	-6,004 Reduced 7.2%	77,417 $2.77 Million
Q1 2023 May 12, 2023	BUY	$23.68 - $38.51 $291,050 - $473,326	12,291 Added 17.28%	83,421 $2.12 Million

Q4 2022 Feb 10, 2023	BUY	$28.0 - $40.56 $204,484 - $296,209	7,303 Added 11.44%	71,130 $2.88 Million
Q3 2022 Nov 01, 2022	BUY	$29.63 - $48.31 $1.89 Million - $3.08 Million	63,827 New	63,827 $2.11 Million
Q2 2022 Aug 09, 2022	BUY	$27.79 - $50.61 $215,039 - $391,620	7,738 Added 13.54%	64,892 $2.28 Million
Q1 2022 May 12, 2022	BUY	$39.62 - $69.97 $194,098 - $342,783	4,899 Added 9.38%	57,154 $2.7 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $193,962 - $275,500	3,339 Added 6.83%	52,255 $3.46 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $516,137 - $751,131	8,841 Added 22.06%	48,916 $3.08 Million
Q2 2021 Aug 11, 2021	BUY	$62.15 - $90.32 $14,853 - $21,586	239 Added 0.6%	40,075 $3.32 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $193,681 - $285,613	-3,157 Reduced 7.34%	39,836 $2.64 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $221,597 - $431,716	-5,057 Reduced 10.52%	42,993 $3.3 Million
Q3 2020 Nov 17, 2020	BUY	$33.21 - $51.27 $92,456 - $142,735	2,784 Added 6.15%	48,050 $2.07 Million
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $341,265 - $526,850	-10,276 Reduced 18.5%	45,266 $1.95 Million
Q2 2020 Aug 17, 2020	BUY	$26.12 - $43.27 $52,866 - $87,578	2,024 Added 3.78%	55,542 $2.4 Million
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $115,094 - $353,345	5,598 Added 11.68%	53,518 $1.54 Million
Q4 2019 Feb 11, 2020	BUY	$28.14 - $73.01 $1.35 Million - $3.5 Million	47,920 New	47,920 $3.04 Million
Q3 2019 Oct 25, 2019	SELL	$26.26 - $34.86 $3.35 Million - $4.44 Million	-127,402 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$17.43 - $28.82 $2.02 Million - $3.33 Million	115,704 Added 989.09%	127,402 $0
Q1 2019 May 08, 2019	BUY	$12.05 - $20.18 $47,187 - $79,024	3,916 Added 50.32%	11,698 $214,000
Q2 2018 Aug 10, 2018	BUY	$6.37 - $14.02 $49,571 - $109,103	7,782 New	7,782 $106,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Arrowhead Pharmaceuticals, Inc. Transaction History